Aurore Vidy, Jamila El Bougrini, Mounira K. Chelbi-Alix, Danielle Blondel, Virologie moléculaire et structurale (VMS), Institut National de la Recherche Agronomique (INRA)-Centre National de la Recherche Scientifique (CNRS), Laboratoire Epigenetique et Cancer, Centre National de la Recherche Scientifique (CNRS), Oncologie virale (OV), and Dambo, Marie-Annie
The interferon (IFN) response is one of the host response system's primary defense mechanisms against viral infection. Type I IFN (alpha/beta interferon [IFN-α/β]) is produced by most cells as a direct response to viral infection, while type II IFN (IFN-γ) is synthesized almost exclusively by activated NK cells and activated T cells in response to virus-infected cells. Both type I and II IFNs achieve antiviral effects by binding to their respective receptors (IFNAR for IFN-α/β or IFNGR for IFN-γ), resulting in the activation of a distinct but related “Janus” tyrosine kinase/signal transducer and activator of transcription (Jak/STAT) pathway (12). Briefly, the interaction of IFN-α/β with IFNAR leads to the activation of the Jak protein tyrosine kinases (Tyk 2 and Jak1) that phosphorylate STAT1 and STAT2. The phosphorylated STATs heterodimerize and bind to a DNA binding protein, IFN regulatory factor 9 (IRF9), to form a complex, IFN-stimulated growth factor 3 (ISGF3). ISGF3 translocates into the nucleus and binds to an IFN-stimulated response element (ISRE) to induce IFN-stimulated genes (ISGs). The binding of IFN-γ to its receptor, IFNGR, results in the phosphorylation of STAT1 by Jak1 and Jak2. STAT1 homodimers form, migrate to the nucleus, and bind to a DNA element termed GAS (for gamma-activated sequence) to induce specifically the transcription of IFN-γ target genes (12). All the IFN-induced biological responses are believed to be mediated by ISG products that have been shown to display intrinsic antiviral activities (8, 24). Viruses that require cellular machinery for their replication have evolved different strategies to counteract IFN action, particularly by altering IFN induction, IFN signaling, and IFN-induced mediators (1, 9, 15). Several viral proteins acting as IFN antagonists have been identified in Mononegavirales, such as members of the Paramyxoviridae families (10, 16). Very recently, interference with IFN production and signaling was described for rabies virus of the Lyssavirus genus that belongs to the Rhabdoviridae family (4, 5, 6, 28). Rabies virus has a linear, nonsegmented, single-strand RNA genome of negative polarity. The ribonucleoprotein contains the RNA genome tightly encapsidated by the viral nucleoprotein (N) and the RNA polymerase complex, which consists of the large protein (L) and its cofactor, the phosphoprotein (P). Both L and P are involved in transcription and replication. A positive-stranded leader RNA and five mRNAs are synthesized during transcription. The replication process yields nucleocapsids containing full-length antisense genome RNA, which in turn serves as a template for the synthesis of sense genome RNA. The rabies virus P protein is a noncatalytic cofactor and a regulatory protein that plays a role in viral transcription and replication: it stabilizes the RNA polymerase L to the N-RNA template and binds to the soluble N, preventing its aggregation and keeping it in a suitable form for specific encapsidation of viral RNA. P protein has other specific functions in the host cells (6). Interestingly, rabies virus P protein interacts directly with two proteins, STAT1 and promyelocytic leukemia protein (PML) (3, 28), playing an important role in the IFN-induced antiviral response. In addition, P protein impairs IRF-3 phosphorylation, leading to the inhibition of IFN production (4). This multifunctionality of P may be linked to the high polymorphism of protein expression. It is phosphorylated by two kinases, rabies virus protein kinase and protein kinase C, leading to the formation of different phosphorylated forms of the P protein (14). In addition, the P gene encodes not only P but also additional shorter P products (P2, P3, P4, and P5) whose translation is initiated from downstream and in-frame AUG codons by a leaky scanning mechanism (7). These small versions of P have different intracellular distributions. The nuclear localizations of P3, P4, and P5 are due to the presence of a nuclear localization signal (NLS) located in the C-terminal part of the protein, whereas the cytoplasmic distributions of P and P2 are the result of a CRM1 nuclear export signal (NES) located in the N-terminal part of the protein (20). We and others have previously shown that rabies virus P protein inhibits signaling by blocking the nuclear accumulation of STAT1 (5, 28). By analyzing the molecular mechanisms leading to the inhibition of IFN signaling by rabies virus P protein, we have shown that P protein and the nuclear P3 isoform inhibit an additional step that occurs in the nucleus: the binding of STAT1 or ISGF3 to the DNA promoters (i.e., to GAS and ISRE) of IFN-γ- or IFN-α-responsive genes, respectively.